This guide helps qualified organizations structure questions, documents, controls, and professional handoffs. It does not determine legal status or replace advice from authorized legal, regulatory, pharmacy, medical, customs, or quality professionals.
Review the net impression, not isolated sentences
FTC guidance directs health-product marketers to identify both express and implied claims and to possess adequate substantiation before disseminating them. The message is created by the complete presentation: words, product name, images, charts, testimonials, omissions, audience, placement, and links.
A sentence that appears carefully qualified may still sit beside imagery or success stories that communicate a stronger therapeutic promise. Reviewers should write down what a reasonable member of the target audience is likely to believe after seeing the entire page or campaign.
Connect claims review to FDA intended use
For peptide products, claims can also affect how intended use is understood. FDA warning letters have cited web statements as evidence that products labeled for research were being offered as drugs for human use. The marketing review therefore needs both an FTC substantiation lens and an FDA classification and intended-use lens.
The approved product strategy should define permitted audiences, claims, scientific topics, imagery, calls to action, customer types, and prohibited content. Changes to any of those elements should trigger review rather than relying on a general disclaimer.
Create a claim-substantiation matrix
A claim matrix records the exact proposed language, the express and implied messages, channel, audience, product, evidence relied upon, limitations, required disclosure, reviewer, and approval date. It prevents a study about one ingredient, dose, route, or population from being stretched into a broader claim for a different product.
The matrix should include SEO titles, descriptions, structured data, ad keywords, image text, video captions, frequently asked questions, chatbot responses, and sales enablement. Content that is technically hidden from a page can still influence search results or customer communications.
- Use only evidence relevant to the exact product and claim.
- Identify important limitations, inconsistent evidence, and material safety information.
- Place necessary qualifications clearly and close to the claim.
- Reapprove content when the evidence, product, audience, or regulatory status changes.
Control testimonials, partners, and scientific content
Testimonials, clinicians, influencers, affiliates, distributors, and agencies can create claims for the marketer. Agreements should require approved content, disclosure of material connections, prompt correction, monitoring cooperation, and preservation of campaign records.
Scientific publications require care in a commercial context. The review should ask whether the cited work involves the same peptide form, formulation, route, dose, population, outcome, and quality as the promoted product—and whether the presentation fairly reflects the full body of relevant evidence.
Operate a living content-control system
A strong program combines prepublication review with channel monitoring, training, version control, complaint and inquiry feedback, and documented correction. High-risk topics should route automatically to legal, medical, and regulatory reviewers.
Pharma Americas Group can help qualified organizations inventory commercial content, organize claim matrices, coordinate approved-copy libraries, and align customer onboarding with the intended-use strategy. Final claim approval and legal conclusions remain with appropriately qualified professionals.
Frequently asked questions
Do disclaimers fix unsupported peptide health claims?
Not necessarily. A disclosure must be clear and cannot contradict the dominant message. FTC evaluates the overall net impression, including implied claims, imagery, testimonials, and omissions.
Are testimonials treated differently from company claims?
A marketer generally cannot use a testimonial or endorsement to communicate a claim that would be deceptive or unsupported if the company made it directly.
Does linking to a scientific study avoid advertising responsibility?
No. Using third-party literature in a promotional context may communicate claims for which the marketer is responsible. Relevance to the exact product, use, population, route, and outcome matters.
Sources and evidence
These primary government and agency resources informed the article’s operating perspective. Regulations, guidance, agency lists, and enforcement information can change. Review the current source and obtain qualified advice for the specific program.
This article provides general operational information current as of July 23, 2026. It is not medical, legal, regulatory, compliance, customs, pharmacy, or quality advice. Requirements vary by product, organization, intended use, pathway, transaction, and jurisdiction and may change. Consult qualified professionals and current official authorities before acting.
Corrections and updates
If you identify a factual error, outdated authority, broken source, or material omission, email the editorial review team. Include the article title, the statement at issue, supporting evidence, and your contact information. Submissions are evaluated against primary sources and the article's stated scope.
A review date changes only after substantive re-evaluation. Material corrections are identified on the affected article; routine copy, formatting, or link maintenance may be corrected without a separate note.
